AmpliPhi Biosciences (TGEN) Establishes Collaboration With Intrexon Corporation
4/16/2013 9:34:08 AM
More...
|
AmpliPhi Biosciences (TGEN) Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy to Treat Drug-Resistant Biofilm-based Infections
2/4/2013 10:22:40 AM
More...
|
Bacteriophage-Based Anti-Infective Companies AmpliPhi Biosciences (TGEN) and Special Phage Services Complete Merger
11/13/2012 10:14:14 AM
More...
|
AmpliPhi Biosciences (TGEN) Presents Encouraging Pre-Clinical Data on the Use of Phage-Based Therapies to Treat Bacterial Lung Infections
10/18/2012 9:37:13 AM
More...
|
AmpliPhi Biosciences (TGEN) to Combine With Special Phage Services to Create World's Leading Anti-Infective Company Focused on Bacteriophage-Based Therapies
9/10/2012 9:54:35 AM
More...
|
AmpliPhi Biosciences (TGEN) to Present at Rodman & Renshaw Global Investment Conference in New York
9/7/2012 1:05:38 PM
More...
|
AmpliPhi Biosciences (TGEN) Shareholder Update
2/1/2012 6:26:51 AM
More...
|
AmpliPhi Biosciences (TGEN) Announces First Closing of $2.7 Million
11/17/2011 7:02:19 AM
More...
|
AmpliPhi Biosciences (TGEN) Appoints Philip J. Young as President & CEO
11/8/2011 6:56:19 AM
More...
|
AmpliPhi Biosciences (TGEN) to Present at Rodman & Renshaw Annual Global Investment Conference in New York
9/6/2011 10:57:24 AM
More...
|
|